The phase 3 trial of Trifluridine/Tipiracil wit
Post# of 145747
Quote:
The phase 3 trial of Trifluridine/Tipiracil with Bevacizumab was not restricted to MSS mCRC. Although most patients are MSS, will this confound the comparison to our trial results?
Being fourth line there is a short timeline to death so there should be little difference between refractory or MSS CRC.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)